Lenka Skálová Selected Research

Lenka Skálová Research Topics

Disease

16	Neoplasms (Cancer) 01/2022 - 07/2002
7	Obesity 10/2021 - 01/2014
4	Cardiotoxicity 07/2019 - 02/2003
4	Intestinal Neoplasms (Intestinal Cancer) 11/2017 - 10/2013
3	Colonic Neoplasms (Colon Cancer) 03/2019 - 02/2016
3	Breast Neoplasms (Breast Cancer) 11/2017 - 10/2008
3	Infections 04/2015 - 12/2008
3	Parasitic Diseases (Parasitic Disease) 09/2010 - 01/2008
2	Hypercholesterolemia 01/2022 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 04/2019 - 01/2018
1	Helminthiasis (Helminthiases) 07/2023
1	HIV Infections (HIV Infection) 01/2022
1	Epilepsy (Aura) 01/2022
1	Mental Disorders (Mental Disorder) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Heart Injuries 07/2019
1	Pathologic Processes 07/2019
1	Non-alcoholic Fatty Liver Disease 01/2019
1	Latent Tuberculosis 08/2017
1	Nematode Infections 02/2015
1	Insulin Resistance 01/2014
1	Abdominal Obesity 01/2014
1	Hepatocellular Carcinoma (Hepatoma) 07/2009

Drug/Important Bio-Agent (IBA)

12	AnthelminticsIBA 07/2023 - 01/2008
10	Doxorubicin (Adriamycin)FDA LinkGeneric 07/2019 - 10/2008
9	flubendazoleIBA 01/2019 - 01/2008
7	benzimidazoleIBA 01/2019 - 01/2008
6	MicroRNAs (MicroRNA)IBA 10/2021 - 01/2014
6	Cytostatic AgentsIBA 03/2019 - 10/2008
6	EnzymesIBA 08/2017 - 05/2004
4	AnthracyclinesIBA 07/2019 - 11/2011
4	caryophyllene oxideIBA 03/2019 - 08/2015
4	nerolidolIBA 03/2019 - 08/2015
4	SesquiterpenesIBA 03/2019 - 08/2015
4	Sodium Glutamate (Accent)IBA 02/2016 - 01/2014
4	AntioxidantsIBA 01/2016 - 11/2011
3	humuleneIBA 03/2019 - 08/2015
3	valenceneIBA 03/2019 - 08/2015
3	Antineoplastic Agents (Antineoplastics)IBA 01/2018 - 07/2002
3	Volatile Oils (Essential Oils)IBA 06/2017 - 08/2015
3	Albendazole (Albenza)FDA Link 04/2015 - 09/2010
3	oracineIBA 01/2013 - 05/2004
2	Biomarkers (Surrogate Marker)IBA 07/2019 - 01/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2019 - 03/2019
2	Fluorouracil (Carac)FDA LinkGeneric 04/2019 - 03/2019
2	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2019 - 01/2016
2	TubulinIBA 01/2019 - 10/2013
2	Mebendazole (Anti-Worm)FDA Link 09/2018 - 04/2015
2	TeaIBA 02/2016 - 01/2014
2	monepantelIBA 02/2015 - 10/2014
1	XenobioticsIBA 01/2022
1	InsecticidesIBA 01/2022
1	HerbicidesIBA 01/2022
1	Glutathione PeroxidaseIBA 10/2021
1	Troponin T (Troponin T1)IBA 07/2019
1	CaspasesIBA 04/2019
1	Irinotecan (Camptosar)FDA LinkGeneric 04/2019
1	OxidesIBA 03/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019
1	Isoproterenol (Isoprenaline)FDA LinkGeneric 01/2019
1	FructoseIBA 01/2019
1	Bevacizumab (Avastin)FDA Link 01/2019
1	Glutathione (Reduced Glutathione)IBA 04/2018
1	PeroxidasesIBA 04/2018
1	Isocitrate LyaseIBA 08/2017
1	glyoxylic acid (glyoxylate)IBA 08/2017
1	IronIBA 08/2017
1	caryophylleneIBA 08/2015
1	acetonitrileIBA 02/2015
1	SolutionsIBA 02/2015
1	NF-E2-Related Factor 2IBA 02/2015
1	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 06/2014
1	Catechin (Z 7300)IBA 06/2014
1	epigallocatechin-(4-8,2-O-7)epicatechinIBA 06/2014
1	mouse MIRN29 microRNAIBA 01/2014
1	LipidsIBA 01/2014
1	Messenger RNA (mRNA)IBA 01/2014
1	PhytochemicalsIBA 01/2014
1	albendazole sulfoxideIBA 10/2013
1	Paclitaxel (Taxol)FDA LinkGeneric 10/2013
1	isoquinolineIBA 01/2013
1	ProdrugsIBA 11/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 11/2011
1	PolymersIBA 11/2011
1	Peptides (Polypeptides)IBA 11/2011
1	AntibodiesIBA 11/2011
1	Antiparasitic Agents (Antiparasitics)IBA 09/2009
1	3-hydroxysteroid dihydrodiol dehydrogenaseIBA 07/2009
1	carbamic acid (ammonium carbamate)IBA 12/2008
1	EstersIBA 12/2008
1	Alcohol OxidoreductasesIBA 10/2008
1	benzo(c)fluoreneIBA 07/2002
1	VUFB 13468IBA 07/2002

Therapy/Procedure

5	Therapeutics 01/2022 - 11/2011
3	Drug Therapy (Chemotherapy) 01/2022 - 05/2004
1	Oral Administration 02/2003